NDTV Profit >> Market Data >> Corporate >> Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd.

Bse Code: 524804 | NSE CODE: AUROPHARMA | Sector: Pharmaceuticals & Drugs

Prev Close

Open

MarketCap(` in Cr.)

Volume (No. of shares)

52 W LOW

52 W HIGH

LOW

HIGH

No Research found.

No Interviews/Opinions found.

Date	announcement / events
Apr 23, 2012 04:54 PM	Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Apr 23, 2012 06:06 PM	Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Apr 25, 2012 03:15 PM	Aurobindo Pharma receives final approval for Olanzapine Tablets
Apr 28, 2012 11:17 AM	Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

No Post available.!

SCHEME	Mkt Value	Holdings(%)
IDFC Premier Equity Fund - Plan A - Growth	22.71	2.08
DSP Black Rock Small and Mid Cap Fund - Regular Plan - Growth	22.47	1.99
Reliance Equity Opportunities Fund - Retail Plan - Growth Plan - Growth Option	20.81	1.29
IDFC Sterling Equity Fund - Growth	18.04	2.18
HSBC Equity Fund - Growth	16.06	1.30

Sudhir B Singhi

Chief Financial Officer

Sudhir B Singhi

Chief Financial Officer

A Mohan Rami Reddy

Registered Office:

Plot No.2
Maitrivihar,
Hyderabad,Andhra Pradesh.

Tel : +91-040-66725000
Fax : +91-040-23746833/23741080

Registrars Details:

Karvy Computershare Pvt Ltd
Plot No 17-24 , Near Image Hospital,,
Reliance Cybervilae,Vithalrao Nagar,,
Madhapur,
Hyderabad

Company	PRICE (`)
Aventis Pharma Ltd.	2,113.300.43
Astrazeneca Pharma India Ltd.	1,541.10-3.89
Abbott India Ltd.	1,468.951.03
Pfizer Ltd.	1,197.55-1.48
Strides Arcolab Ltd.	687.005.86